EBookClubs

Read Books & Download eBooks Full Online

EBookClubs

Read Books & Download eBooks Full Online

Book Drug Industry Antitrust Act

Download or read book Drug Industry Antitrust Act written by United States. Congress. Senate. Committee on the Judiciary and published by . This book was released on 1961 with total page 1366 pages. Available in PDF, EPUB and Kindle. Book excerpt:

Book Drug Industry Antitrust Act

Download or read book Drug Industry Antitrust Act written by United States. Congress. House. Committee on the Judiciary and published by . This book was released on 1962 with total page 938 pages. Available in PDF, EPUB and Kindle. Book excerpt: Committee Serial No. 32. Considers legislation to eliminate anticompetitive practices in the patenting, licensing, and marketing of drugs, and to require FDA standardization of drug names and stricter safety and efficacy standards for new drugs.

Book Pharmaceutical Industry Antitrust Handbook

Download or read book Pharmaceutical Industry Antitrust Handbook written by and published by American Bar Association. This book was released on 2009 with total page 484 pages. Available in PDF, EPUB and Kindle. Book excerpt:

Book Individual Statements by Physicians  Research Scientists  and Medical Educators on S 1552

Download or read book Individual Statements by Physicians Research Scientists and Medical Educators on S 1552 written by United States. Congress. Senate. Committee on the Judiciary and published by . This book was released on 1961 with total page 236 pages. Available in PDF, EPUB and Kindle. Book excerpt:

Book Drug Industry Antitrust Act

Download or read book Drug Industry Antitrust Act written by and published by . This book was released on 1962 with total page 0 pages. Available in PDF, EPUB and Kindle. Book excerpt:

Book Drug Industry Antitrust Act

    Book Details:
  • Author : United States. Congress. Senate. Committee on the Judiciary
  • Publisher :
  • Release : 1961
  • ISBN :
  • Pages : pages

Download or read book Drug Industry Antitrust Act written by United States. Congress. Senate. Committee on the Judiciary and published by . This book was released on 1961 with total page pages. Available in PDF, EPUB and Kindle. Book excerpt:

Book Administered Prices  Drugs

    Book Details:
  • Author : United States. Congress. Senate. Committee on the Judiciary. Subcommittee on Antitrust and Monopoly
  • Publisher :
  • Release : 1961
  • ISBN :
  • Pages : 390 pages

Download or read book Administered Prices Drugs written by United States. Congress. Senate. Committee on the Judiciary. Subcommittee on Antitrust and Monopoly and published by . This book was released on 1961 with total page 390 pages. Available in PDF, EPUB and Kindle. Book excerpt:

Book The Pharmaceutical Industry

Download or read book The Pharmaceutical Industry written by Roy Levy and published by DIANE Publishing. This book was released on 1999 with total page 226 pages. Available in PDF, EPUB and Kindle. Book excerpt:

Book Patent Settlements in the Pharmaceutical Industry under US Antitrust and EU Competition Law

Download or read book Patent Settlements in the Pharmaceutical Industry under US Antitrust and EU Competition Law written by Amalia Athanasiadou and published by Kluwer Law International B.V.. This book was released on 2018-08-14 with total page 520 pages. Available in PDF, EPUB and Kindle. Book excerpt: Reverse payment settlements or “pay-for-delay agreements” between originators and generic drug manufacturers create heated debates regarding the balance between competition and intellectual property law. These settlements touch upon sensitive issues such as timely generic entry and access to affordable pharmaceuticals and also the need to preserve innovation incentives for originators and to strengthen the pipeline of life-saving pharmaceuticals. This book is one of the first to critically and comparatively analyse how such patent settlements and various other strategies employed by the pharmaceutical industry are scrutinised by both United States (US) and European courts and enforcement authorities, and to discuss the applicable legal tests and the main criteria used for their assessment. The book’s ultimate objective is to provide guidance to the pharmaceutical industry regarding the types of patent settlements, strategies and conduct which may be problematic from US antitrust and European Union (EU) competition law perspectives and to assist practitioners in structuring settlements which are both efficient and compliant. To this end, an exhaustive legal analysis of some of the most controversial issues regarding pharmaceutical patent settlements is provided, including: – the lengthy split among US Circuit Courts on the issue of pay-for-delay settlements, its resolution by the US Supreme Court in FTC v. Actavisand subsequent jurisprudence; – the decision of Lundbeck v. Commissionby the European General Court and the Servier decision of the European Commission; – the Roche/Novartisdecision of the European Court of Justice and the most important decisions by National Competition Authorities on pharma patent settlements in the EU; – an overview of other types of strategies such as product-hopping and product reformulations, no-authorised generic commitments, problematic side-deals, mechanisms affecting generic substitution; – the rejection of the “scope of the patent” test in both the US and the EU and the balancing of patent law and antitrust law considerations in the prevailing applicable tests; – the benefits of settlements and the main criteria for assessing their legitimacy under US antitrust and EU competition law. The analysis provides concrete examples of both illegitimate and legitimate settlements and strategies, emphasising on conduct that falls within a grey zone and on the circumstances and criteria under which such conduct could be deemed problematic from an antitrust perspective. This book will serve as a valuable guide for pharmaceutical companies wishing to minimise the risk of engaging in conduct that could potentially infringe US antitrust and EU competition law. It further aims to save courts and enforcement agencies and also practitioners and academics considerable time and resources by providing an exhaustive analysis of the relevant caselaw, with the ultimate goal to increase legal certainty on the most controversial aspects of patent settlements in the pharmaceutical industry.

Book Drug Industry Antitrust Act

Download or read book Drug Industry Antitrust Act written by and published by . This book was released on 1962 with total page 908 pages. Available in PDF, EPUB and Kindle. Book excerpt:

Book The Jungle

Download or read book The Jungle written by Upton Sinclair and published by . This book was released on 1920 with total page 442 pages. Available in PDF, EPUB and Kindle. Book excerpt:

Book Small Business Problems in the Drug Industry

Download or read book Small Business Problems in the Drug Industry written by United States. Congress. House. Select Committee on Small Business. Subcommittee on Activities of Regulatory Agencies and published by . This book was released on 1967 with total page 978 pages. Available in PDF, EPUB and Kindle. Book excerpt: Examines impact of pharmaceutical industry pricing policies on small firms, focusing on practices which allegedly violate antitrust laws. Part two continuation of hearings on the impact of pharmaceutical industry retail, wholesale, and manufacturing practices on small business.

Book Drug Industry Antitrust Act

Download or read book Drug Industry Antitrust Act written by United States. Congress. Senate. Committee on the Judiciary and published by . This book was released on 1961 with total page 818 pages. Available in PDF, EPUB and Kindle. Book excerpt:

Book Drug Industry Antitrust Act  87 1 2

Download or read book Drug Industry Antitrust Act 87 1 2 written by United States. Congress. Senate. Judiciary and published by . This book was released on 1961 with total page 1928 pages. Available in PDF, EPUB and Kindle. Book excerpt: Considers S. 1552 and companion H.R. 6245, the Drug Industry Antitrust Act, to amend the Federal Food, Drug, and Cosmetic Act and Sherman Antitrust Act to establish drug company licensing procedures, to require FDA to certify the effectiveness of all new drugs, to require advertisements sent to physicians to contain FDA warnings on the drug, and to limit drug company rights to exclusive production of patented drugs.

Book The Drug Control Bills and Other Proposals to Amend the Food  Drug and Cosmetic Act

Download or read book The Drug Control Bills and Other Proposals to Amend the Food Drug and Cosmetic Act written by American Enterprise Institute for Public Policy Research and published by . This book was released on 1962 with total page 74 pages. Available in PDF, EPUB and Kindle. Book excerpt: